Here we go again...... Most penny OTC companies use pump and dump "IR" firms who get paid lots of restricted stock at a discount to put out bogus pumping reports. I don't see that here, do you? I see an individual analyst who has done reports for NASDAQ and NYSE traded companies in the bio/health fields, who got paid a small amount of money. He is also using market accepted formulas and principles for his estimates. Maybe when the company retains an investment banking firm, they will do a report too, but I am sure it will cost a LOT more than this one.
So the company "commissioning" a report for themselves is way better than a pump and dump "IR" firm doing so. Its positive - NOT NEGATIVE. I think this was a wise use of company funds instead of diluting shareholders.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.